Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
325
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

228
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
228

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mycobacterium tuberculosis transmission from tuberculosis patients with and without recognized symptoms: a case-contact study in eastern China.

Nature communications·2026
Same author

The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward.

The Lancet. Infectious diseases·2026
Same author

Uncovering household tuberculosis infection testing and care patterns using a novel bioinformatics linkage strategy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Mycobacterium tuberculosis transmission in China during the COVID-19 pandemic period (2020-2021) compared with the pre-pandemic period (2017-2019).

Nature communications·2025
Same author

Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent- Driven Sampling Study in the Western Cape, South Africa.

The Journal of infectious diseases·2025

相关实验视频

Updated: Jun 29, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K

多种药物耐药性结核病

Keertan Dheda1,2, Fuad Mirzayev3, Daniela Maria Cirillo4

  • 1Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa. keertan.dheda@uct.ac.za.

Nature reviews. Disease primers
|March 25, 2024
PubMed
概括
此摘要是机器生成的。

多耐药结核病 (MDR-TB) 和广泛耐药结核病 (XDR-TB) 构成了全球健康的重大威胁. 新的诊断和治疗方法可用,但对管理这些复杂的耐药结核病形式的指导是有限的.

更多相关视频

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

100

相关实验视频

Last Updated: Jun 29, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

100

科学领域:

  • 传染性疾病 传染性疾病
  • 公共卫生 公共卫生
  • 微生物学 微生物学

背景情况:

  • 结核病 (TB) 是全球领先的传染病杀手.
  • 耐药结核病 (DR-TB),包括多耐药结核病 (MDR-TB) 和广泛耐药结核病 (XDR-TB),是全球日益严重的公共卫生问题.
  • 耐药性结核病带来了诊断和治疗的挑战,高死亡率和增加的医疗保健成本.

研究的目的:

  • 提供对耐药结核病 (DR-TB) 的全面概述.
  • 解决关于管理MDR-TB和XDR-TB的有限指南,特别是针对初级保健医生.
  • 涵盖了DR-TB的发病,传播,诊断,管理和预防.

主要方法:

  • 审查关于DR-TB的当前文献.
  • 对结核病诊断和治疗的最新进展进行分析.
  • 综合了关于DR-TB的临床和公共卫生方面的信息.

主要成果:

  • 抗药性结核病,包括前广泛耐药性结核病 (前XDR-TB) 和XDR-TB,越来越普遍且难以治疗.
  • 尽管取得了进展,但在诊断,管理和预防方面仍然存在重大挑战.
  • 耐药结核菌株与耐药结核病一样易传播,但死亡率和发病率更高.

结论:

  • 为了有效管理DR-TB,医疗保健提供者需要更新指导和策略.
  • 持续研究和开发新的诊断和治疗方法至关重要.
  • 解决DR-TB对于全球结核病控制工作至关重要,特别是在高负担地区.